Kenvue seeks label approval from the FDA, utilizing DailyMed for official submissions under a Congressional framework.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Kenvue →

  American consumer health company

  • Kenvue is pursuing a $40 billion mega-merger with Kimberly-Clark.Mon 07:23
  • IWS filed required documents with the Securities and Exchange Commission on June 6, 2026, detailing institutional investor holdings.Sun 18:49
• Congress →

  US record label; imprint of Congress Record Corp.

  • Mandated National Bridge Inspection Standards were established in 1968.Mon 16:46
  • AIPAC questions the terms of a potential US-Iran deal regarding Iran's nuclear program, while Trump aims to end the program and demands Congress receive deal information.Mon 15:37

Related events

• Humane World for Animals petitioned the FDA and lobbied Congress regarding drug approval regulations.Sep 22
• The FDA and Intellia Therapeutics are preparing a regulatory filing for product approval.Jun 24
• Future sales of a product are contingent upon obtaining the necessary FDA registration and labeling, while the state simultaneously announces actions to remove regulatory barriers.Sep 21
• FDA approval enables commercial opportunity involving CBRE Group.Sep 17
• Decoy Therapeutics is listed on the Nasdaq stock exchange and is currently seeking expedited regulatory approval via FDA pathways.Sep 22